Søgeresultater - X. Wei Meng
- Showing 1 - 15 results of 15
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Poly(ADP-ribose) Polymerase Inhibitors Sensitize Cancer Cells to Death Receptor-mediated Apoptosis by Enhancing Death Receptor Expression af X. Wei Meng, Brian D. Koh, Jin‐San Zhang, Karen S. Flatten, Paula A. Schneider, Daniel D. Billadeau, Allan D. Hess, Benjamin D. Smith, Judith E. Karp, Scott H. Kaufmann
Udgivet 2014Artigo -
9
-
10
CXCR4 Chemokine Receptor Signaling Induces Apoptosis in Acute Myeloid Leukemia Cells via Regulation of the Bcl-2 Family Members Bcl-XL, Noxa, and Bak af Kimberly N. Kremer, Kevin L. Peterson, Paula A. Schneider, X. Wei Meng, Haiming Dai, Allan D. Hess, B. Douglas Smith, Christie Rodriguez-Ramirez, Judith E. Karp, Scott H. Kaufmann, Karen E. Hedin
Udgivet 2013Artigo -
11
Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells af Zhang Js, Marta Herreros‐Villanueva, Alexander Köenig, Zhi-Hui Deng, A A-M de Narvajas, Timothy S. Gomez, X. Wei Meng, Luís Bujanda, Volker Ellenrieder, X K Li, Scott H. Kaufmann, Daniel D. Billadeau
Udgivet 2014Artigo -
12
Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells af Barbara Schroeder, Travis Vander Steen, Ingrid Espinoza, Chandra M. K. Venkatapoorna, Zeng Hu, Fernando Martín, Kevin M. Regan, Elisabet Cuyàs, X. Wei Meng, Sara Verdura, Aina Arbusà, Paula A. Schneider, Karen S. Flatten, George Kemble, Joan Montero, Scott H. Kaufmann, Javier A. Menéndez, Ruth Lupu
Udgivet 2021Artigo -
13
In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma af Mariam AlHilli, Marc A. Becker, S. John Weroha, Karen S. Flatten, Rachel M. Hurley, Maria I. Harrell, Ann L. Oberg, Matt Maurer, Kieran Hawthorne, Xiaonan Hou, Sean C. Harrington, Sarah McKinstry, X. Wei Meng, Keith Wilcoxen, Kimberly R. Kalli, Elizabeth M. Swisher, Scott H. Kaufmann, Paul Haluska
Udgivet 2016Artigo -
14
BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma af Cristina Correia, Paula A. Schneider, Haiming Dai, Ahmet Doǧan, Matthew J. Maurer, Amy K. Church, Anne J. Novak, Andrew L. Feldman, Xiaosheng Wu, Husheng Ding, X. Wei Meng, James R. Cerhan, Susan L. Slager, William R. Macon, Thomas M. Habermann, Judith E. Karp, Steven D. Gore, Neil E. Kay, Diane F. Jelinek, Thomas E. Witzig, Grzegorz S. Nowakowski, Scott H. Kaufmann
Udgivet 2014Artigo -
15
53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer af Rachel M. Hurley, Andrea E. Wahner Hendrickson, Daniel W. Visscher, Peter Ansell, Maria I. Harrell, Jill M. Wagner, Vivian Negron, Krista M. Goergen, Matthew J. Maurer, Ann L. Oberg, X. Wei Meng, Karen S. Flatten, Maja J.A. de Jonge, Carla D. Van Herpen, Jourik A. Gietema, Rutger H.T. Koornstra, Agnes Jager, Martha W. den Hollander, Matthew W. Dudley, Stacie Peacock Shepherd, Elizabeth M. Swisher, Scott H. Kaufmann
Udgivet 2019Artigo
Søgeredskaber:
Relaterede emner
Biology
Cancer research
Biochemistry
Cell biology
Gene
Apoptosis
Genetics
Chemistry
Programmed cell death
Cancer
Gene knockdown
Molecular biology
Immunology
Mitochondrion
PARP inhibitor
Poly ADP ribose polymerase
Polymerase
Receptor
Annexin
Bcl-2 family
Biophysics
Cancer cell
Cytoplasm
DNA
Downregulation and upregulation
Homologous recombination
Internal medicine
Medicine
Mutant
Olaparib